|
 |
Huntingtons Disease > Refractory Period
The following information is about Refractory Period.
Refractory Period Defined
In a voltage-gated ion channel, the stage between open and closed. During this time the channel is inactivated, no molecules are allowed in or out, and the channel cannot be excited further.
This definition is in context to Huntingtons Disease. See more contextual defintions for Refractory Period.
Valeant Pharmaceuticals and GlaxoSmithKline Announce Worldwide Collaboration Agreement for Retigabine
Published August 28, 2008, 5:00 am, Business Wire via Yahoo! Finance
ALISO VIEJO, Calif. & LONDON----Valeant Pharmaceuticals International and GlaxoSmithKline today announced that they have entered into an exclusive worldwide collaboration agreement for the investigational drug retigabine, a first in class neuronal potassium channel opener for treatment of adult epilepsy patients with refractory partial onset seizures.
New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously ...
Published August 27, 2008, 2:00 pm, PR Newswire via Yahoo! Finance
Millennium: The Takeda Oncology Company today announced the publication of results from the 682 patient, randomized, Phase III VISTA trial in this week's edition of the New England Journal of Medicine.
Genmab Has Announced Plans To Begin Four Studies Of Ofatumumab In Chronic Lymphocytic Leukemia And Non-Hodgkin's ...
Published August 27, 2008, 3:14 am, Medical News Today
Genmab A/S (OMX: GEN) announced plans to begin four studies of ofatumumab in chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin's lymphoma (NHL) this year. "Genmab and GSK have worked diligently to expand the ofatumumab development program to maximize the value of the antibody for patients and shareholders since our collaboration began," said Lisa N. Drakeman, Ph.D.
Genmab plans to start ofatumumab studies in CLL & NHL
Published August 26, 2008, 12:43 am, PharmaBiz
Genmab A/S announced plans to begin four studies of ofatumumab in chronic lymphocytic leukaemia (CLL) and follicular non-Hodgkin's lymphoma (NHL) this year.
Genmab announces four studies of ofatumumab in chronic lymphocytic leukemia
Published August 25, 2008, 3:43 am, News-Medical-Net
Genmab A/S announced today plans to begin four studies of ofatumumab in chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin's lymphoma (NHL) this year.
Genmab Announces Upcoming Ofatumumab Studies
Published August 25, 2008, 12:40 am, PR Newswire via Yahoo! Finance
Genmab has announced plans to begin four studies of ofatumumab in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Are you looking for additional Huntingtons Disease > Refractory Period news? Try our new "Refractory Period News Focus" area.
Off-site Refractory Period Links, User Submitted
The following links have been collected through user bookmark submission in the Refractory Period category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Tue Feb 14
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Refractory Period. If you would like to find related tags we recommend Tag Patterns > Refractory Period
Off-site Refractory Period Research Links
If you still need additional information on Refractory Period then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
- A9 > Refractory Period
- Alexa > Refractory Period
- Anti-Aging Revolution > Refractory Period
- DMOZ > Refractory Period
- Feeds Filtered > Refractory Period
- Google > Refractory Period
- News Meme > Refractory Period
- Nuah: News > Refractory Period
- The Feed Directory > Refractory Period
- OBP > Refractory Period
- Open Tag Directory > Refractory Period
- Podzy > Refractory Period
- Yahoo > Refractory Period
Huntingtons Disease Topics
Everything you need to know about Huntingtons Disease
Huntingtons Disease
If you know the Huntingtons Disease Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Huntingtons-Disease.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.